BioCentury
ARTICLE | Company News

Oncor, Boston University School of Medicine deal

July 8, 1996 7:00 AM UTC

ONC's OncorPharm affiliate acquired an option for an exclusive worldwide right to develop pharmaceuticals based on an existing drug candidate, dithymidine, and future drug candidates from the universi...